Acoramidis Hydrochloride

Category Pipeline APIs

Details	Specifications
CAS Number	2242751-53-5
Molecular Formula	C15H18ClFN2O3
Molecular Weight	328.77 g/mol.
Synonyms	Acoramidis Hydrochloride
Chemical Name	3-[3-(3,5-dimethyl-1H-pyrazol-4-yl) propoxy]-4-fluorobenzoic acid hydrochloride
Therapeutic use	Transthyretin (TTR) Stabilizer
Status	Tech pack available
Background	Acoramidis hydrochloride (brand name Attruby) is an oral, highly selective transthyretin (TTR) stabilizer approved by the FDA in Nov 2024 to treat transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-CM).
Grade	In house
Polymorph	Form A
Storage Temperature	Controlled room temperature (20?C ? 25?C)

Please Note: We partner exclusively with pharmaceutical manufacturers, biotech companies, and international trading firms. Minimum order quantities apply*

Disclaimer:

The information provided on this webpage is based on the best available knowledge at the time of publication; however, accuracy and completeness are not guaranteed. Product specifications may change without notice. It is the responsibility of the purchaser or user to verify suitability and compliance. This product is intended for research use only and is not approved for human consumption.

Why Shilpa Pharma?

Happy Customers

Projects Successfully Completed

Established

PhD Experts Driving R&D Excellence

Team Size

World-Class API Manufacturing Sites

Global Audits Successfully Completed

Comprehensive CDMO Service Offerings

Our Acoramidis Hydrochloride are also Available for

Questions & Answers

FAQ on Acoramidis Hydrochloride

Everything You Need to Know About Shilpa Pharma

Shilpa Pharma – Your Trusted Global CDMO Partner

Delivering end-to-end solutions across API oncology, generics, peptides, polymers and specialty chemicals, we empower partners to accelerate development, ensure compliance, and reach markets faster with reliable, cost-effective innovation.